BRK.B's Q3 earnings may decline despite revenue growth. Strong insurance operations, a robust cash position and attractive valuation support its appeal.

Berkshire Hathaway Inc.’s $360B cash pile and diversified earnings offer downside protection amid AI/tech volatility. Click ...

Buffett's acquisition of OxyChem is a model for how to invest when the market as a whole is expensive. The core of his approach is to buy absolute value and ignore market opinions. The context for ...

Looking ahead to 2030, our model projects BRK-B could trade at an average price of $737.33, with a potential range between $553.00 and $921.66. This represents a potential 36.8% return from today’s ...